EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GH: Guardant Health Inc

07 Nov 25 15:59
LAST:

96.72

CHANGE:
 0.47		OPEN:
95.02		HIGH:
96.77		ASK:
0.00		VOLUME:
1.66M
CHG(%):
0.49		PREV:
96.25		LOW:
92.54		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2595.0896.7792.5496.722.75M
06 Nov 2595.0197.5189.6896.254.02M
05 Nov 2592.7595.2488.8895.059.81M
04 Nov 2593.40100.2293.0598.143.07M
03 Nov 2594.0799.2392.5798.922.69M
31 Oct 2591.3993.6688.6893.024.05M
30 Oct 2589.9995.8888.2292.4111.1M
29 Oct 2569.1773.1568.0272.274.73M
28 Oct 2570.8570.8568.3369.581.93M
27 Oct 2572.5673.3170.0170.851.97M

COMPANY PROFILE

Name:Guardant Health Inc
About:Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Sector:Healthcare
Address:3100 Hanover Street, Palo Alto, CA, United States, 94304
Website:https://guardanthealth.com
CUSIP:40131M109
CIK:0001576280
ISIN:US40131M1099
FIGI:BBG006D97VY9
LEI:254900M8C3E5VC8BR186

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-27.79 
Forward P/E:-34.32 
PEG Ratio:5.84 
Price to Sales:12.99 
Price to Book:-40.19 
Profit Margin:-0.44 
Operating Margin:-0.37 
Return on Assets:-0.20 
Return on Equity:3.12 
EPS Ratio:-3.35 
Revenue:902.57M 
Shares:124.71M 
Market Cap:12.062B 

TECHNICAL INDICATORS

MA5:97.020.3%
MA10:88.329.5%
MA20:77.5924.7%
MA50:67.5243.2%
MA100:59.4362.7%
MA200:51.7886.8%
STO9:88.58 
STO14:89.30 
RSI14:79.61 
WPR14:-7.00 
MTM14:29.21
ROC14:0.43 
ATR:6.21 
Week High:100.223.6%
Week Low:88.689.1%
Month High:100.223.6%
Month Low:61.0086.8%
Year High:100.223.6%
Year Low:28.20243.0%